FIRE • Flagstaff International Relief Efforts

Email

mpotts@fireprojects.org

Phone

T: +976 70101810

Web

www.fireprojects.org

Address

PO 44, Box 870 Ulaanbaatar Ulaanbaatar 14250 Mongolia
About FIRE • Flagstaff International Relief Efforts

FIRE – Flagstaff International Relief Effort, is a non-profit, non-government organization (NGO), headquartered in Flagstaff, Arizona with a registered NGO branch office in Ulaanbaatar, Mongolia, and team representatives in Langtang and Kathmandu, Nepal. FIRE began its work in 1999, in the devastated economy of post-Soviet Mongolia on the foundation of “placing aid directly in the hands of the people.” FIRE continually evolves, meeting the challenges of a rapidly changing world. Through sustainable and award-winning programming with a focus on research, development, and evaluation, FIRE empowers communities and individuals. Our responsible, multi-layered programs work with partners at all levels — local, national and international — including government, civil society, and individuals.

Since 2009, FIRE has provided 8,526 people in 7 provinces with comprehensive liver and cancer screenings; distributed 78,500 pieces of community awareness materials; vaccinated 3,022 people; trained 3,571 health care workers; distributed 155,000 sharps containers and $1,000,000 in medical supplies; distributed 2,000 health safety training videos.

In 2016, FIRE was recognized by the World Health Organization (WHO) and the European Association for the Study of the Liver (EASL) as one of five “Innovative Hepatitis Screening Projects” in the world. In 2017 FIRE’s hepatitis work in Mongolia was featured three times in the "Economist Intelligence Unit." FIRE continues to design and implement programs that are culturally sensitive, focused on rural, underserved populations, that can be replicated in other countries and communities throughout the world. Over the years, FIRE’s working partnerships have included the Mongolian Ministry of Health, the World Health Organization (WHO), the National Institutes of Health (NIH), the Asian Development Bank (ADB), the Canadian Society for International Health (CSIH), the Asian Liver Center at Stanford University, the American Embassy in Ulaanbaatar, countless state organizations and hospitals across Mongolia and more.

 Mission

FIRE works to improve health and development through value-centered, community-based programs encompassing cultural diversity and heritage.

Vision

Communities around the world are empowered with a higher quality of life through access to safe health care and sustainable resources for responsible development.

Sign up to receive updates from WHA

Name(Required)
I would like to hear about(Required)

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

tHIS

 

IS 

 

BEN’S

 

 

 

BIG 

 

 

TEST

effective case finding strategies

Supported by Vir Biotechnology, Inc

During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.

Session Agenda

14:40 – 14:45    

Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)

14:45 – 15:05   

Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology

15:05 – 15:10    

Final remarks and close